As shown in Fig. 1a, PD1 expression on T-cells increased with disease stage with pT3-4 RCC tumours, locally advanced tumours and metastatic sites displaying the highest expression of PD-1 on CD4+ and CD8+T-cells. This evidence concerns the gene CD4 and neoplasm.